Eisai May Start Skin-Patch Aricept U.S. Sales in 2011 - Bloomberg

Eisai May Start Skin-Patch Aricept U.S. Sales in 2011 - Bloomberg: "Teikoku Seiyaku Co., Eisai’s development partner, submitted patient-trial data to the U.S. Food and Drug Administration on June 30, Lynn Kramer, head of neuroscience product development at the Tokyo-based company, said on a conference call today. The regulator typically takes 10 months to complete a review."